BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31495875)

  • 1. Kinetic and subcellular analysis of PS-ASO/protein interactions with P54nrb and RNase H1.
    Vickers TA; Rahdar M; Prakash TP; Crooke ST
    Nucleic Acids Res; 2019 Nov; 47(20):10865-10880. PubMed ID: 31495875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of phosphorothioate oligonucleotides with RNase H1 can cause conformational changes in the protein and alter the interactions of RNase H1 with other proteins.
    Zhang L; Vickers TA; Sun H; Liang XH; Crooke ST
    Nucleic Acids Res; 2021 Mar; 49(5):2721-2739. PubMed ID: 33577678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NAT10 and DDX21 Proteins Interact with RNase H1 and Affect the Performance of Phosphorothioate Oligonucleotides.
    Zhang L; Bernardo KD; Vickers TA; Tian J; Liang XH; Crooke ST
    Nucleic Acid Ther; 2022 Aug; 32(4):280-299. PubMed ID: 35852833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsp90 protein interacts with phosphorothioate oligonucleotides containing hydrophobic 2'-modifications and enhances antisense activity.
    Liang XH; Shen W; Sun H; Kinberger GA; Prakash TP; Nichols JG; Crooke ST
    Nucleic Acids Res; 2016 May; 44(8):3892-907. PubMed ID: 26945041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute hepatotoxicity of 2' fluoro-modified 5-10-5 gapmer phosphorothioate oligonucleotides in mice correlates with intracellular protein binding and the loss of DBHS proteins.
    Shen W; De Hoyos CL; Sun H; Vickers TA; Liang XH; Crooke ST
    Nucleic Acids Res; 2018 Mar; 46(5):2204-2217. PubMed ID: 29390093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorothioate modified oligonucleotide-protein interactions.
    Crooke ST; Vickers TA; Liang XH
    Nucleic Acids Res; 2020 Jun; 48(10):5235-5253. PubMed ID: 32356888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-endosomal trafficking mediated by lysobisphosphatidic acid contributes to intracellular release of phosphorothioate-modified antisense oligonucleotides.
    Wang S; Sun H; Tanowitz M; Liang XH; Crooke ST
    Nucleic Acids Res; 2017 May; 45(9):5309-5322. PubMed ID: 28379543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specific replacement of phosphorothioate with alkyl phosphonate linkages enhances the therapeutic profile of gapmer ASOs by modulating interactions with cellular proteins.
    Migawa MT; Shen W; Wan WB; Vasquez G; Oestergaard ME; Low A; De Hoyos CL; Gupta R; Murray S; Tanowitz M; Bell M; Nichols JG; Gaus H; Liang XH; Swayze EE; Crooke ST; Seth PP
    Nucleic Acids Res; 2019 Jun; 47(11):5465-5479. PubMed ID: 31034558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COPII vesicles can affect the activity of antisense oligonucleotides by facilitating the release of oligonucleotides from endocytic pathways.
    Liang XH; Sun H; Nichols JG; Allen N; Wang S; Vickers TA; Shen W; Hsu CW; Crooke ST
    Nucleic Acids Res; 2018 Nov; 46(19):10225-10245. PubMed ID: 30239896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the effect of controlling phosphorothioate chirality in the DNA gap on the potency and safety of gapmer antisense oligonucleotides.
    Østergaard ME; De Hoyos CL; Wan WB; Shen W; Low A; Berdeja A; Vasquez G; Murray S; Migawa MT; Liang XH; Swayze EE; Crooke ST; Seth PP
    Nucleic Acids Res; 2020 Feb; 48(4):1691-1700. PubMed ID: 31980820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index.
    Shen W; De Hoyos CL; Migawa MT; Vickers TA; Sun H; Low A; Bell TA; Rahdar M; Mukhopadhyay S; Hart CE; Bell M; Riney S; Murray SF; Greenlee S; Crooke RM; Liang XH; Seth PP; Crooke ST
    Nat Biotechnol; 2019 Jun; 37(6):640-650. PubMed ID: 31036929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of ASOs with PC4 Is Highly Influenced by the Cellular Environment and ASO Chemistry.
    Vickers TA; Migawa MT; Seth PP; Crooke ST
    J Am Chem Soc; 2020 May; 142(21):9661-9674. PubMed ID: 32374993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of intracellular proteins that bind oligonucleotides with phosphorothioate linkages.
    Liang XH; Sun H; Shen W; Crooke ST
    Nucleic Acids Res; 2015 Mar; 43(5):2927-45. PubMed ID: 25712094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rates of the major steps in the molecular mechanism of RNase H1-dependent antisense oligonucleotide induced degradation of RNA.
    Vickers TA; Crooke ST
    Nucleic Acids Res; 2015 Oct; 43(18):8955-63. PubMed ID: 26384424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some ASOs that bind in the coding region of mRNAs and induce RNase H1 cleavage can cause increases in the pre-mRNAs that may blunt total activity.
    Liang XH; Nichols JG; De Hoyos CL; Crooke ST
    Nucleic Acids Res; 2020 Sep; 48(17):9840-9858. PubMed ID: 32870273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCP1 complex proteins interact with phosphorothioate oligonucleotides and can co-localize in oligonucleotide-induced nuclear bodies in mammalian cells.
    Liang XH; Shen W; Sun H; Prakash TP; Crooke ST
    Nucleic Acids Res; 2014 Jul; 42(12):7819-32. PubMed ID: 24861627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNase H1-Dependent Antisense Oligonucleotides Are Robustly Active in Directing RNA Cleavage in Both the Cytoplasm and the Nucleus.
    Liang XH; Sun H; Nichols JG; Crooke ST
    Mol Ther; 2017 Sep; 25(9):2075-2092. PubMed ID: 28663102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annexin A2 facilitates endocytic trafficking of antisense oligonucleotides.
    Wang S; Sun H; Tanowitz M; Liang XH; Crooke ST
    Nucleic Acids Res; 2016 Sep; 44(15):7314-30. PubMed ID: 27378781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular uptake mediated by epidermal growth factor receptor facilitates the intracellular activity of phosphorothioate-modified antisense oligonucleotides.
    Wang S; Allen N; Vickers TA; Revenko AS; Sun H; Liang XH; Crooke ST
    Nucleic Acids Res; 2018 Apr; 46(7):3579-3594. PubMed ID: 29514240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Golgi-58K can re-localize to late endosomes upon cellular uptake of PS-ASOs and facilitates endosomal release of ASOs.
    Liang XH; Nichols JG; De Hoyos CL; Sun H; Zhang L; Crooke ST
    Nucleic Acids Res; 2021 Aug; 49(14):8277-8293. PubMed ID: 34244781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.